biospecimen_aliquot__bcr_aliquot_barcode	tcga-e2-a10b-01a-11d-a10m-09
biospecimen_aliquot__bcr_aliquot_uuid	9d712002-74cb-459a-b350-e9a4b49aac13
biospecimen_aliquot__bcr_patient_uuid	f801aeed-dc43-49d7-a319-84c8851979d9
biospecimen_aliquot__bcr_sample_barcode	tcga-e2-a10b-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0100474429
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.07
biospecimen_aliquot__date_of_shipment	2010-12-14
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	2
biospecimen_aliquot__plate_id	a10m
biospecimen_aliquot__plate_row	g
biospecimen_aliquot__quantity	1.82
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	26.00
biospecimen_analyte__a260_a280_ratio	1.83
biospecimen_analyte__analyte_type	dna
biospecimen_analyte__analyte_type_id	d
biospecimen_analyte__bcr_analyte_barcode	tcga-e2-a10b-01a-11d
biospecimen_analyte__bcr_analyte_uuid	bcc1f1ce-3146-4ed3-b798-1eaec5b25e8e
biospecimen_analyte__bcr_patient_uuid	f801aeed-dc43-49d7-a319-84c8851979d9
biospecimen_analyte__bcr_sample_barcode	tcga-e2-a10b-01a
biospecimen_analyte__concentration	0.13
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__spectrophotometer_method	uv spec
biospecimen_analyte__subportion_sequence	1
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-e2-a10b
biospecimen_diagnostic_slides__bcr_patient_uuid	f801aeed-dc43-49d7-a319-84c8851979d9
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-e2-a10b-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	148cfc4b-ee65-4a7e-918f-10c72f37cb0f
biospecimen_normal_control__bcr_patient_barcode	tcga-e2-a10b
biospecimen_normal_control__bcr_patient_uuid	f801aeed-dc43-49d7-a319-84c8851979d9
biospecimen_normal_control__ncedna_dna_conc	.1875
biospecimen_normal_control__ncedna_dna_qm	nanodrop and picogreen
biospecimen_normal_control__ncedna_dna_qty	20
biospecimen_normal_control__ncedna_dna_vol	107
biospecimen_portion__bcr_patient_uuid	f801aeed-dc43-49d7-a319-84c8851979d9
biospecimen_portion__bcr_portion_barcode	tcga-e2-a10b-01a-11
biospecimen_portion__bcr_portion_uuid	82e2eef2-7d2c-4aa4-a174-1d75acdc3fde
biospecimen_portion__bcr_sample_barcode	tcga-e2-a10b-01a
biospecimen_portion__date_of_creation	2010-11-24
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	11
biospecimen_portion__portion_sequence	1
biospecimen_portion__weight	30.00
biospecimen_protocol__bcr_analyte_barcode	tcga-e2-a10b-01a-11d
biospecimen_protocol__bcr_patient_uuid	f801aeed-dc43-49d7-a319-84c8851979d9
biospecimen_protocol__bcr_sample_barcode	tcga-e2-a10b-01a
biospecimen_protocol__experimental_protocol_type	adna preparation type
biospecimen_sample__bcr_patient_uuid	f801aeed-dc43-49d7-a319-84c8851979d9
biospecimen_sample__bcr_sample_barcode	tcga-e2-a10b-01a
biospecimen_sample__bcr_sample_uuid	5f5cddc0-71d3-4bf4-a67c-66550596cf8d
biospecimen_sample__days_to_collection	1065
biospecimen_sample__initial_weight	210
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	false
biospecimen_sample__pathology_report_file_name	tcga-e2-a10b.5dac95dd-5da6-475b-ac14-5c79fc2f30a6.pdf
biospecimen_sample__pathology_report_uuid	5dac95dd-5da6-475b-ac14-5c79fc2f30a6
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_shipment_portion__bcr_patient_uuid	f801aeed-dc43-49d7-a319-84c8851979d9
biospecimen_shipment_portion__bcr_sample_barcode	tcga-e2-a10b-01a
biospecimen_shipment_portion__bcr_shipment_portion_uuid	f0d6030f-5893-4ff7-8072-b4ecafb7a860
biospecimen_shipment_portion__center_id	20
biospecimen_shipment_portion__is_ffpe	no
biospecimen_shipment_portion__plate_id	a13d
biospecimen_shipment_portion__portion_number	21
biospecimen_shipment_portion__portion_sequence	2
biospecimen_shipment_portion__shipment_portion_bcr_aliquot_barcode	tcga-e2-a10b-01a-21-a13d-20
biospecimen_shipment_portion__shipment_portion_day_of_shipment	22
biospecimen_shipment_portion__shipment_portion_month_of_shipment	3
biospecimen_shipment_portion__shipment_portion_year_of_shipment	2011
biospecimen_slide__bcr_patient_uuid	f801aeed-dc43-49d7-a319-84c8851979d9
biospecimen_slide__bcr_sample_barcode	tcga-e2-a10b-01a
biospecimen_slide__bcr_slide_barcode	tcga-e2-a10b-01a-01-ts1
biospecimen_slide__bcr_slide_uuid	3bfc66da-c6c4-4246-8794-4b477deba098
biospecimen_slide__image_file_name	tcga-e2-a10b-01a-01-ts1.3bfc66da-c6c4-4246-8794-4b477deba098.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	60
biospecimen_slide__percent_monocyte_infiltration	10
biospecimen_slide__percent_necrosis	10
biospecimen_slide__percent_neutrophil_infiltration	10
biospecimen_slide__percent_normal_cells	0
biospecimen_slide__percent_stromal_cells	20
biospecimen_slide__percent_tumor_cells	70
biospecimen_slide__percent_tumor_nuclei	70
biospecimen_slide__section_location	top
biospecimen_tumor_sample__bcr_patient_barcode	tcga-e2-a10b
biospecimen_tumor_sample__bcr_patient_uuid	f801aeed-dc43-49d7-a319-84c8851979d9
clinical_drug__bcr_drug_barcode	tcga-e2-a10b-d7778
clinical_drug__bcr_drug_uuid	22a0ab43-d0fb-443a-9af6-411f57558645
clinical_drug__bcr_patient_barcode	tcga-e2-a10b
clinical_drug__bcr_patient_uuid	f801aeed-dc43-49d7-a319-84c8851979d9
clinical_drug__form_completion_date	2011-2-14
clinical_drug__pharmaceutical_therapy_drug_name	arimidex
clinical_drug__pharmaceutical_therapy_type	hormone therapy
clinical_drug__pharmaceutical_tx_dose_units	mg/day
clinical_drug__pharmaceutical_tx_ongoing_indicator	yes
clinical_drug__pharmaceutical_tx_started_days_to	232
clinical_drug__pharmaceutical_tx_total_dose_units	mg/day
clinical_drug__prescribed_dose	1
clinical_drug__regimen_number	1
clinical_drug__route_of_administration	po
clinical_drug__therapy_regimen	adjuvant
clinical_drug__total_dose	1
clinical_follow_up__bcr_followup_barcode	tcga-e2-a10b-f17370
clinical_follow_up__bcr_followup_uuid	276dd2fd-d528-42ef-a703-fd3cc598295e
clinical_follow_up__bcr_patient_barcode	tcga-e2-a10b
clinical_follow_up__bcr_patient_uuid	f801aeed-dc43-49d7-a319-84c8851979d9
clinical_follow_up__days_to_additional_surgery_metastatic_procedure	195
clinical_follow_up__followup_reason	scheduled follow-up submission
clinical_follow_up__form_completion_date	2011-9-19
clinical_follow_up__last_contact_days_to	1141
clinical_follow_up__new_tumor_event_dx_days_to	195
clinical_follow_up__new_tumor_event_dx_indicator	yes
clinical_follow_up__new_tumor_event_pharmaceutical_tx	yes
clinical_follow_up__new_tumor_event_radiation_tx	yes
clinical_follow_up__new_tumor_event_site	lung
clinical_follow_up__new_tumor_event_surgery	yes
clinical_follow_up__new_tumor_event_type	new primary tumor
clinical_follow_up__nte_er_status	negative
clinical_follow_up__nte_pr_status_by_ihc	negative
clinical_follow_up__radiation_treatment_adjuvant	yes
clinical_follow_up__targeted_molecular_therapy	yes
clinical_follow_up__vital_status	alive
clinical_patient__age_at_diagnosis	67
clinical_patient__ajcc_metastasis_pathologic_pm	m0
clinical_patient__ajcc_nodes_pathologic_pn	n1a
clinical_patient__ajcc_pathologic_tumor_stage	stage iib
clinical_patient__ajcc_staging_edition	6th
clinical_patient__ajcc_tumor_pathologic_pt	t2
clinical_patient__anatomic_neoplasm_subdivision	left lower outer quadrant
clinical_patient__axillary_staging_method	sentinel lymph node biopsy plus axillary dissection
clinical_patient__bcr_patient_barcode	tcga-e2-a10b
clinical_patient__bcr_patient_uuid	f801aeed-dc43-49d7-a319-84c8851979d9
clinical_patient__birth_days_to	-24577
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_positivity_method	allred score 5+3= 8
clinical_patient__er_positivity_scale_other	allred score 8
clinical_patient__er_status_by_ihc	positive
clinical_patient__ethnicity	not hispanic or latino
clinical_patient__form_completion_date	2011-2-22
clinical_patient__gender	female
clinical_patient__her2_cent17_ratio	1.11
clinical_patient__her2_fish_status	negative
clinical_patient__her2_ihc_percent_positive	10-19%
clinical_patient__her2_ihc_score	2+
clinical_patient__her2_status_by_ihc	equivocal
clinical_patient__histological_type	infiltrating ductal carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	no
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8500/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2007
clinical_patient__last_contact_days_to	748
clinical_patient__lymph_nodes_examined_count	28
clinical_patient__lymph_nodes_examined_he_count	2
clinical_patient__lymph_nodes_examined_ihc_count	0
clinical_patient__margin_status	close
clinical_patient__menopause_status	post (prior bilateral ovariectomy or >12 mo since lmp with no prior hysterectomy)
clinical_patient__method_initial_path_dx	core needle biopsy
clinical_patient__micromet_detection_by_ihc	no
clinical_patient__patient_id	a10b
clinical_patient__pr_positivity_define_method	allred score 5+3= 8
clinical_patient__pr_positivity_scale_other	allred score 8
clinical_patient__pr_status_by_ihc	positive
clinical_patient__prospective_collection	no
clinical_patient__race	white
clinical_patient__retrospective_collection	yes
clinical_patient__surgical_procedure_first	lumpectomy
clinical_patient__tissue_source_site	e2
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
clinical_radiation__bcr_patient_barcode	tcga-e2-a10b
clinical_radiation__bcr_patient_uuid	f801aeed-dc43-49d7-a319-84c8851979d9
clinical_radiation__bcr_radiation_barcode	tcga-e2-a10b-r17417
clinical_radiation__bcr_radiation_uuid	7db115f8-d3d7-46cf-8652-9c5c37f11fac
clinical_radiation__course_number	1
clinical_radiation__form_completion_date	2011-9-19
clinical_radiation__radiation_adjuvant_fractions_total	30
clinical_radiation__radiation_adjuvant_units	cgy
clinical_radiation__radiation_therapy_ended_days_to	413
clinical_radiation__radiation_therapy_ongoing_indicator	no
clinical_radiation__radiation_therapy_site	primary tumor field
clinical_radiation__radiation_therapy_started_days_to	368
clinical_radiation__radiation_therapy_type	external beam
clinical_radiation__radiation_total_dose	6000
clinical_radiation__therapy_regimen	adjuvant
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-E2-A10B-01A-11D-A10M-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-E2-A10B-01A-11D-A10M-09.bed.meta
manually_curated__id	tcga-e2-a10b-01a-11d-a10m-09
manually_curated__md5sum	d3f67a0ecbb3e028631119207376158b
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	9d712002-74cb-459a-b350-e9a4b49aac13
manually_curated__tumor_tag	brca
